Testing effectiveness (Phase 2)Study completedNCT00855868
What this trial is testing
Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals
Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 28